NASD · Healthcare · Medical Devices · USA
Quanterix Corp is a micro cap company (market value under $300 million) in the Medical Devices industry.
Quanterix Corp develops instruments and reagents for detecting protein biomarkers at extremely low concentrations using its Simoa technology and spatial biology platforms. The company sells its products and provides laboratory testing services to research institutions, pharmaceutical companies, contract research organizations, and academic centers worldwide.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Quanterix Corp stock.
Slightly undervalued: intrinsic value $3.44 per share, market price $2.86, margin of safety 16.9% (as of 2026-11-17).
A 0.8x revenue multiple, discounted for its losses, values the shares at $3.44; the price of $2.86 is 17% below that value.
17 more funds hold it; the full list is part of the paid plan.
All 140 Medical Devices stocks
9 more in this industry show a wider margin of safety.
QTRX is slightly undervalued (as of the 2026-11-17 close). A 0.8x revenue multiple, discounted for its losses, values the shares at $3.44; the price of $2.86 is 17% below that value.
$3.44 per share (as of the 2026-11-17 close), against a market price of $2.86. That is a margin of safety of 16.9%. The value comes from the one valuation method that applies to this company, recomputed every night after the US close.